Kouvaraki Maria A, Greer Marilyn, Sharma Sheena, Beery David, Armand Robert, Lee Jeffrey E, Evans Douglas B, Perrier Nancy D
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-1402, USA.
Surgery. 2006 Apr;139(4):527-34. doi: 10.1016/j.surg.2005.09.006.
Currently, many patients with primary hyperparathyroidism (PHPT) are diagnosed when they are considered to be "asymptomatic." The need for parathyroidectomy in these patients has been questioned. A consensus statement drafted after the National Institutes of Health (NIH) 2002 Workshop on Asymptomatic PHPT provided guidelines for management of such patients but has been criticized for being too conservative. The purpose of this survey was to determine the impact of these guidelines on practice patterns of endocrine surgeons.
Members of the American Association of Endocrine Surgeons (AAES) were surveyed to determine whether previously published consensus guidelines for management of asymptomatic patients with PHPT are used to base the decision of whether to offer parathyroidectomy and to ascertain what parameters are considered indicators to proceed with operative intervention. AAES members were asked about the management of patients with asymptomatic PHPT, specialty characteristics, and demographics.
Of 257 AAES members, 96 (37%) responded to the survey. Although the majority of the respondents were aware of and followed the NIH consensus conference guidelines, the majority of surgeons (80%) would operate on a patient with PHPT who did not meet these criteria but had other nonspecific symptoms. Surgeons favored operative intervention when preoperative localization studies were positive, even if the criteria of the NIH guidelines were not fulfilled. Most of the responders who would operate on all patients with PHPT, regardless of objective parameters, were surgeons with a high-volume practice (>30 parathyroidectomies per year). The presence of multiple endocrine neoplasia (MEN) syndromes did not alter the decision to operate on asymptomatic patients.
Endocrine surgeons do not base the decision to intervene operatively in patients with PHPT solely on objective criteria. Most high-volume, experienced endocrine surgeons believe that subjective complaints warrant operative intervention.
目前,许多原发性甲状旁腺功能亢进症(PHPT)患者在被认为“无症状”时被诊断出来。这些患者是否需要进行甲状旁腺切除术一直受到质疑。美国国立卫生研究院(NIH)2002年无症状PHPT研讨会后起草的一份共识声明为这类患者的管理提供了指导方针,但因过于保守而受到批评。本调查的目的是确定这些指导方针对内分泌外科医生的实践模式的影响。
对美国内分泌外科医生协会(AAES)的成员进行调查,以确定之前发表的无症状PHPT患者管理的共识指导方针是否被用于决定是否进行甲状旁腺切除术,并确定哪些参数被视为进行手术干预的指标。向AAES成员询问无症状PHPT患者的管理、专业特点和人口统计学情况。
257名AAES成员中,96名(37%)回复了调查。虽然大多数受访者了解并遵循NIH共识会议的指导方针,但大多数外科医生(80%)会对不符合这些标准但有其他非特异性症状的PHPT患者进行手术。当术前定位研究呈阳性时,即使不符合NIH指南的标准,外科医生也倾向于手术干预。大多数无论客观参数如何都会对所有PHPT患者进行手术的受访者是手术量大的外科医生(每年>30例甲状旁腺切除术)。多发性内分泌肿瘤(MEN)综合征的存在并没有改变对无症状患者进行手术的决定。
内分泌外科医生并非仅根据客观标准来决定对PHPT患者进行手术干预。大多数手术量大、经验丰富的内分泌外科医生认为主观症状值得进行手术干预。